<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><description>【国内外药讯，医药市场，医药数据分享】</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 09 May 2021 21:28:33 +0800</pubDate><image><url>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</url><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>复星医药猛Do mRNA疫苗，预计10亿级产量</title><link>https://mp.weixin.qq.com/s/2YjGQXdTDmVtexnkxh-t8Q</link><description></description><content:encoded><![CDATA[复星医药猛Do mRNA疫苗，预计10亿级产量]]></content:encoded><pubDate>Sun, 09 May 2021 21:08:09 +0800</pubDate></item><item><title>国内溶瘤病毒药企春天？这家单轮融资破5亿</title><link>https://mp.weixin.qq.com/s/gre4R589-GZTCU4hY2bcYQ</link><description></description><content:encoded><![CDATA[国内溶瘤病毒药企春天？这家单轮融资破5亿]]></content:encoded><pubDate>Sun, 09 May 2021 21:08:09 +0800</pubDate></item><item><title>阿可拉定上市申请拟纳入优先审评，盛诺基冲刺科创板！</title><link>https://mp.weixin.qq.com/s/13p3JNLLbyDZ8IelLJLPLg</link><description></description><content:encoded><![CDATA[阿可拉定上市申请拟纳入优先审评，盛诺基冲刺科创板！]]></content:encoded><pubDate>Sat, 08 May 2021 16:13:48 +0800</pubDate></item><item><title>重磅！高瓴资本即将完成180亿美元基金募资</title><link>https://mp.weixin.qq.com/s/9DiqQ_hz2vQwzR2vuptMKw</link><description></description><content:encoded><![CDATA[重磅！高瓴资本即将完成180亿美元基金募资]]></content:encoded><pubDate>Sat, 08 May 2021 16:13:48 +0800</pubDate></item><item><title>重磅！石药/倍而达三代EGFR抑制剂瑞泽替尼胶囊申报上市</title><link>https://mp.weixin.qq.com/s/RIQ57PhPU8tgQciXln65Mg</link><description></description><content:encoded><![CDATA[重磅！石药/倍而达三代EGFR抑制剂瑞泽替尼胶囊申报上市]]></content:encoded><pubDate>Fri, 07 May 2021 14:28:23 +0800</pubDate></item><item><title>百济神州PARP抑制剂百汇泽®（帕米帕利）获批上市</title><link>https://mp.weixin.qq.com/s/BHhB49ed932R2PNCuTbfLQ</link><description></description><content:encoded><![CDATA[百济神州PARP抑制剂百汇泽®（帕米帕利）获批上市]]></content:encoded><pubDate>Fri, 07 May 2021 14:28:23 +0800</pubDate></item><item><title>君实生物PD-1/TGF-β 双功能融合蛋白获批临床</title><link>https://mp.weixin.qq.com/s/1IHbgHk5ZSdWFKF0fjejzw</link><description></description><content:encoded><![CDATA[君实生物PD-1/TGF-β 双功能融合蛋白获批临床]]></content:encoded><pubDate>Fri, 07 May 2021 14:28:23 +0800</pubDate></item><item><title>北海康成1.2亿美元又引进一款罕见病新药</title><link>https://mp.weixin.qq.com/s/Z-eS4HvO4ZHT1aQTTk5ysQ</link><description></description><content:encoded><![CDATA[北海康成1.2亿美元又引进一款罕见病新药]]></content:encoded><pubDate>Thu, 06 May 2021 08:12:45 +0800</pubDate></item><item><title>投入2400万元，人福又一款新药获批临床！</title><link>https://mp.weixin.qq.com/s/E8SFdXXiRXN4TFW0viR2ZQ</link><description></description><content:encoded><![CDATA[投入2400万元，人福又一款新药获批临床！]]></content:encoded><pubDate>Thu, 06 May 2021 08:12:45 +0800</pubDate></item><item><title>投入445万元，恒瑞又一款3类药获批上市</title><link>https://mp.weixin.qq.com/s/7TMA-sUsI_lABs6jSFZ8tQ</link><description></description><content:encoded><![CDATA[投入445万元，恒瑞又一款3类药获批上市]]></content:encoded><pubDate>Thu, 06 May 2021 08:12:45 +0800</pubDate></item><item><title>远大控股超4.7亿元收购凯立生物</title><link>https://mp.weixin.qq.com/s/2J5RW2yNGHU-VFFrUVN4sA</link><description></description><content:encoded><![CDATA[远大控股超4.7亿元收购凯立生物]]></content:encoded><pubDate>Tue, 04 May 2021 07:51:07 +0800</pubDate></item><item><title>加科思KRAS G12C抑制剂新药临床试验申请在美国获批</title><link>https://mp.weixin.qq.com/s/aurfCa2LYo7sKmTcyQIMxg</link><description></description><content:encoded><![CDATA[加科思KRAS G12C抑制剂新药临床试验申请在美国获批]]></content:encoded><pubDate>Tue, 04 May 2021 07:51:07 +0800</pubDate></item><item><title>恒瑞PD-1抗体获得FDA授予孤儿药资格！</title><link>https://mp.weixin.qq.com/s/m1A2Dux1-WX-KIQV7zISJQ</link><description></description><content:encoded><![CDATA[恒瑞PD-1抗体获得FDA授予孤儿药资格！]]></content:encoded><pubDate>Tue, 04 May 2021 07:43:01 +0800</pubDate></item><item><title>又一药企拟被出售……</title><link>https://mp.weixin.qq.com/s/gOtMQEC9unpHiXHwvZOLOQ</link><description></description><content:encoded><![CDATA[又一药企拟被出售……]]></content:encoded><pubDate>Tue, 04 May 2021 07:43:01 +0800</pubDate></item><item><title>恒瑞创新再下一城！卡瑞利珠单抗鼻咽癌新适应症获批</title><link>https://mp.weixin.qq.com/s/l-urMk4gDxmUE8Gkda32cw</link><description></description><content:encoded><![CDATA[恒瑞创新再下一城！卡瑞利珠单抗鼻咽癌新适应症获批]]></content:encoded><pubDate>Tue, 04 May 2021 07:43:01 +0800</pubDate></item><item><title>上海市国资委控股的这家医药企业即将申报科创板</title><link>https://mp.weixin.qq.com/s/yN3gmtN_x3U22ZjGiLSVow</link><description></description><content:encoded><![CDATA[上海市国资委控股的这家医药企业即将申报科创板]]></content:encoded><pubDate>Thu, 29 Apr 2021 08:46:55 +0800</pubDate></item><item><title>缔脉和Clinipace合并，加速客户成功</title><link>https://mp.weixin.qq.com/s/z7DTvoUCwlCi8pTwZgEv-w</link><description></description><content:encoded><![CDATA[缔脉和Clinipace合并，加速客户成功]]></content:encoded><pubDate>Thu, 29 Apr 2021 08:46:55 +0800</pubDate></item><item><title>Adcentrx Therapeutics完成由康桥资本领投的五千万美元A轮融资</title><link>https://mp.weixin.qq.com/s/YtgoF9zSZV30bd4eIip_RQ</link><description></description><content:encoded><![CDATA[Adcentrx Therapeutics完成由康桥资本领投的五千万美元A轮融资]]></content:encoded><pubDate>Thu, 29 Apr 2021 08:46:55 +0800</pubDate></item><item><title>研发新型RNA药物的Turn完成最新一轮融资</title><link>https://mp.weixin.qq.com/s/Q2WCKWla_8DrrfEy45Ji0w</link><description></description><content:encoded><![CDATA[研发新型RNA药物的Turn完成最新一轮融资]]></content:encoded><pubDate>Thu, 29 Apr 2021 08:46:55 +0800</pubDate></item><item><title>估值6.5亿元！华东医药收购道尔生物，开启生物药并购热潮？</title><link>https://mp.weixin.qq.com/s/ORn1C1J7aHAiGqGlBbjXHg</link><description></description><content:encoded><![CDATA[估值6.5亿元！华东医药收购道尔生物，开启生物药并购热潮？]]></content:encoded><pubDate>Wed, 28 Apr 2021 13:52:27 +0800</pubDate></item></channel></rss>